{"organizations": [], "uuid": "6491177f5e7055e38ecbfe68f7d0d6744bafcfd2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/rite-aid-corp-results/drug-retailer-rite-aids-revenue-misses-estimates-idUSL3N1RP4FI", "country": "US", "domain_rank": 408, "title": "Drug retailer Rite Aid's revenue misses estimates", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-12T14:07:00.000+03:00", "replies_count": 0, "uuid": "6491177f5e7055e38ecbfe68f7d0d6744bafcfd2"}, "author": "", "url": "https://www.reuters.com/article/rite-aid-corp-results/drug-retailer-rite-aids-revenue-misses-estimates-idUSL3N1RP4FI", "ord_in_thread": 0, "title": "Drug retailer Rite Aid's revenue misses estimates", "locations": [], "entities": {"persons": [{"name": "vibhuti sharma", "sentiment": "none"}, {"name": "sriraj kalluvila", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "rite aid", "sentiment": "negative"}, {"name": "drug retailer rite aid", "sentiment": "negative"}, {"name": "albertsons cos inc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 12, 2018 / 11:09 AM / Updated 16 minutes ago Drug retailer Rite Aid's revenue misses estimates Reuters Staff 1 Min Read \nApril 12 (Reuters) - Drug retailer Rite Aid, which is being bought by U.S. grocer Albertsons Cos Inc, posted smaller-than-expected fourth-quarter revenue, hurt by a decline in commercial business and prescription volumes. \nRevenue fell to $5.39 billion from $5.9 billion. \nAnalysts had expected revenue of $5.57 billion, according to Thomson Reuters I/B/E/S. (Reporting by Vibhuti Sharma in Bengaluru; Editing by Sriraj Kalluvila)", "external_links": [], "published": "2018-04-12T14:07:00.000+03:00", "crawled": "2018-04-12T14:26:59.001+03:00", "highlightTitle": ""}